niflumic acid (Compound)

Synonyms:niflumic acid, 4394-00-7, Landruma, Nifluril, Forenol, Nifluminic acid, Niflugel, Acido niflumico, Acide niflumique, UP 83, 2-{[3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid, Acide niflumique [INN-French], Acido niflumico [INN-Spanish], Acidum niflumicum [INN-Latin], 2-(3-(Trifluoromethyl)anilino)nicotinic acid, 2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid, 2-(3-(Trifluoromethyl)-phenyl)aminonicotinic acid, 2-(3-Trifluoromethylanilino)nicotinic Acid, 2-((3-(Trifluoromethyl)phenyl)amino)nicotinic acid, 2-[3-(Trifluoromethyl)anilino]nicotinic acid, 3-Pyridinecarboxylic acid, 2-[[3-(trifluoromethyl)phenyl]amino]-, Lopac-N-0630, 2-(3-(Trifluoromethyl)phenylamino)nicotinic acid, Niflumic acid (INN), 2-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}NICOTINIC ACID, NSC-758196, 2-[(3-TRIFLUOROMETHYL)PHENYL]AMINO-3-PYRIDINE-CARBOXYLIC ACID, 4U5MP5IUD8, Niflumic Acid-d5 (Major), MLS000069713, NFL, DTXSID1023368, CHEBI:34888, 3-Pyridinecarboxylic acid, 2-((3-(trifluoromethyl)phenyl)amino)-, UP-83, NCGC00015724-10, Niflumate, SMR000058199, CAS-4394-00-7, 2-(3-[Trifluoromethyl]anilino)nicotinic acid, Acidum niflumicum, NIFLUMIC ACID [INN], Acide niflumique [French], Acido niflumico [Italian], DTXCID903368, Niflamol, Niflugel (TN), SC 1332, CCRIS 5740, 1794811-58-7, SR-01000000231, 2-(alpha,alpha,alpha-Trifluoro-m-toluidino)nicotinic acid, EINECS 224-516-2, 2-(3-Trifluoromethyl-phenylamino)-nicotinic acid, UNII-4U5MP5IUD8, BRN 0489360, 2-[[3-(trifluoromethyl)phenyl]amino]pyridine-3-carboxylic acid, niflumic-acid, ni-flumic acid, Niflumic acid [INN:BAN:DCF], Actol, analgesic, Aza-2 dimethyl-2',3' (tetrazolyl-5)-6 diphenylamino [French], Prestwick_890, MFCD00010569, Aza-2 dimethyl-2',3' (tetrazolyl-5)-6 diphenylamino, Spectrum_001353, 1td7, Opera_ID_1746, Prestwick0_000255, Prestwick1_000255, Prestwick2_000255, Prestwick3_000255, Spectrum2_000794, Spectrum3_001485, Spectrum4_000043, Spectrum5_001216, Niflumic acid (Hit 16), N 0630, NIFLUMIC ACID [MI], 2-[(3-Trifluoromethylphenyl)amino]nicotinic Acid, CBiol_001828, Lopac0_000845, SCHEMBL24706, BSPBio_000070, BSPBio_001393, BSPBio_003069, KBioGR_000113, KBioGR_000505, KBioSS_000113, KBioSS_001833, 5-22-13-00598 (Beilstein Handbook Reference), MLS001076327, CHEMBL63323, DivK1c_000277, SPECTRUM1502015, SPBio_000928, SPBio_002289, NIFLUMIC ACID [MART.], BPBio1_000078, GTPL2439, NIFLUMIC ACID [WHO-DD], BDBM85507, HMS500N19, KBio1_000277, KBio2_000113, KBio2_001833, KBio2_002681, KBio2_004401, KBio2_005249, KBio2_006969, KBio3_000225, KBio3_000226, KBio3_002569, NINDS_000277, 2-[(3-Trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic Acid, Bio1_000114, Bio1_000603, Bio1_001092, Bio2_000113, Bio2_000593, HMS1361F15, HMS1568D12, HMS1791F15, HMS1921D12, HMS1989F15, HMS2090D19, HMS2095D12, HMS2234F11, HMS3262J11, HMS3374H01, HMS3402F15, HMS3649A08, HMS3656P14, HMS3712D12, HMS3885I03, Nicotinic acid, 2-(alpha,alpha,alpha-trifluoro-m-toluidino)-, Pharmakon1600-01502015, HY-B0493, NIFLUMIC ACID [EP IMPURITY], NSC_4488, Tox21_110206, Tox21_500845, BBL003619, CCG-40157, DL-457, Nicotinic acid, 2-(.alpha.,.alpha.,.alpha.-trifluoro-m-toluidino)-, NIFLUMIC ACID [EP MONOGRAPH], NSC758196, s3018, STK803109, AKOS000519590, Tox21_110206_1, AC-2652, DB04552, GS-3202, LP00845, NSC 758196, SDCCGSBI-0050821.P004, IDI1_000277, IDI1_033863, NCGC00015724-01, NCGC00015724-02, NCGC00015724-03, NCGC00015724-04, NCGC00015724-05, NCGC00015724-06, NCGC00015724-07, NCGC00015724-08, NCGC00015724-09, NCGC00015724-11, NCGC00015724-12, NCGC00015724-13, NCGC00015724-14, NCGC00015724-17, NCGC00015724-29, NCGC00023636-03, NCGC00023636-04, NCGC00023636-05, NCGC00023636-06, NCGC00023636-07, NCGC00023636-08, NCGC00023636-09, NCGC00261530-01, CAS_4394-00-7, SBI-0050821.P003, 2(3'-trifluormethylanilino)-nicotinic acid, AB00052255, AM20070143, EU-0100845, FT-0603659, SW197011-3, T2353, EN300-17360, A23222, D08275, H10042, S00109, AB00052255-17, AB00052255_18, AB00052255_19, 2-((3-(Trifluoromethyl)phenyl)amino)nicotinicacid, Q304285, SR-01000000231-2, SR-01000000231-5, SR-01000000231-6, W-106215, BRD-K98763141-001-04-3, BRD-K98763141-001-06-8, BRD-K98763141-001-17-5, SR-01000000231-11, Z56922127, 2-[3-(Trifluoromethyl)anilino]-3-pyridinecarboxylic acid, Niflumic acid, European Pharmacopoeia (EP) Reference Standard
Pubchem:PUBCHEM:4488
Id:3343d058-8ae5-56a5-87a5-27b125b77328
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View niflumic acid's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for niflumic acid.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with niflumic acid.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.